Skip to content

#monoclonal

5 public questions tagged with this topic.

Hybridoma technology involves fusion of:

Hybridoma formation relies on merging two complementary cellular programs within one cytoplasm to create self-renewing antibody factory. Splenic B lymphocytes from immunized donor possess productively rearranged heavy chain locus on chromosome 14 with VDJ recombination mediated by RAG1/2 and light chain kappa or lambda locus with VJ recombination, encoding high-affinity combining site selected through germinal center affinity maturation involving activation-induced deaminase, but they senesce within days after extraction due to lack of telomerase, dependence on BAFF survival signal, and activa

Ref: Janeway Immunobiology 9th ed monoclonal generation; J Genet Eng Biotechnol 2020 PMC7414427 hybridoma fusion B myeloma.

Monoclonal antibodies are produced by:

Mammalian antibody-secreting plasma cells are terminally differentiated, possessing an extensively expanded endoplasmic reticulum and unfolded protein response activated to sustain immunoglobulin production at up to 10,000 molecules per second, but these cells quickly trigger p53 dependent apoptosis and survive only days in vitro. To overcome limited lifespan, Georges Kohler and Cesar Milstein in 1975 created hybridoma technology that couples specificity donor with immortal partner. Splenic B lymphocytes isolated from hyperimmunized mouse provide functional heavy and light chain loci after som

Ref: Kohler & Milstein Nature 1975 256:495 hybridoma; Alberts Molecular Biology of Cell 6th ed Chapter 8 monoclonal production.

Polyclonal antibodies differ from monoclonal antibodies because they:

Immunization with a complex protein or whole pathogen simultaneously displays many surface features that can be recognized by the adaptive immune system. Each epitope activates distinct naive B cells bearing complementary B cell receptors generated through VDJ recombination and junctional diversity, driving clonal expansion in germinal centers with help from follicular helper T cells. Differentiation produces plasma cells secreting antibodies with different paratopes, isotypes, and affinities that collectively coat the same antigen particle. The resulting serum therefore constitutes a heteroge

Ref: Kuby Immunology 8th ed Chapter 4 Antibody binding; Janeway Immunobiology NCBI Bookshelf NBK27130 polyclonal multi-epitope recognition.

Monoclonal antibodies are produced by:

Monoclonal antibodies originate immortalized hybridoma lines fusing single antibody-secreting B lymphocyte with myeloma partner preserving exactly one immunoglobulin gene rearrangement producing uniform paratope. Protocol begins immunization BALB/c mice purified antigen HER2 extracellular domain mixed Freund's adjuvant stimulating germinal center spleen. Four days after final booster splenocytes enriched plasma blasts expressing high-affinity surface IgG harvested. Fusion mediated PEG 1500 or electrofusion aligning cells pearl chains creates heterokaryons containing nuclei both parents tetrapl

Ref: Kohler and Milstein Nature 1975 Hybridoma Monoclonal Generation; Janeway Hybridoma Technology Production Chapter 5; Lodish Antibody Production Hybridoma Cells Method.

Polyclonal antibodies differ from monoclonal antibodies because they:

Polyclonal antibody preparations heterogeneous mixture immunoglobulin molecules diverse B lymphocyte clones responding complex immunogen multiple antigenic determinants repetitive epitopes. Each naive B cell generates unique BCR random recombination RAG-mediated VDJ joining heavy chain variable diversity joining segments VJ joining light chain kappa lambda diversified junctional addition non-templated nucleotides TdT and somatic hypermutation germinal centers introducing point mutations rate 10^-3 per base division selecting higher affinity via follicular dendritic cell presentation. Immunizat

Ref: Janeway Immunobiology 9th ed Polyclonal vs Monoclonal Diversity Chap 5; NCBI Bookshelf Antibody Diversity Mechanism; Campbell Immunology Antibody Response Polyepitopic.